Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02842125
Title Safety and Efficacy of Intra-Arterial and Intra-Tumoral Ad-p53 With Capecitabine (Xeloda) or Anti-PD-1 in Liver Metastases of Solid Tumors and Recurrent Head and Neck Squamous Cell Cancer
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors MultiVir, Inc.
Indications

hepatocellular carcinoma

Advanced Solid Tumor

Therapies

Ad5CMV-p53 gene + Pembrolizumab

Ad5CMV-p53 gene + Capecitabine

Ad5CMV-p53 gene + Nivolumab

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST